دورية أكاديمية

Sequential use of midazolam and dexmedetomidine for long-term sedation may reduce weaning time in selected critically ill, mechanically ventilated patients: a randomized controlled study

التفاصيل البيبلوغرافية
العنوان: Sequential use of midazolam and dexmedetomidine for long-term sedation may reduce weaning time in selected critically ill, mechanically ventilated patients: a randomized controlled study
المؤلفون: Yongfang Zhou, Jie Yang, Bo Wang, Peng Wang, Zhen Wang, Yunqin Yang, Guopeng Liang, Xiaorong jing, Xiaodong Jin, Zhongwei Zhang, Yiyun Deng, Chenggong Hu, Xuelian Liao, Wanhong Yin, Zhihong Tang, Yongming Tian, Liyuan Tao, Yan Kang
المصدر: Critical Care, Vol 26, Iss 1, Pp 1-11 (2022)
بيانات النشر: BMC, 2022.
سنة النشر: 2022
المجموعة: LCC:Medical emergencies. Critical care. Intensive care. First aid
مصطلحات موضوعية: Midazolam, Propofol, Dexmedetomidine, Sequential sedation, Critically ill, Mechanical ventilation, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
الوصف: Abstract Background Current sedatives have different side effects in long-term sedation. The sequential use of midazolam and dexmedetomidine for prolonged sedation may have distinct advantages. We aimed to evaluate the efficacy and safety of the sequential use of midazolam and either dexmedetomidine or propofol, and the use of midazolam alone in selected critically ill, mechanically ventilated patients. Methods This single-center, randomized controlled study was conducted in medical and surgical ICUs in a tertiary, academic medical center. Patients enrolled in this study were critically ill, mechanically ventilated adult patients receiving midazolam, with anticipated mechanical ventilation for ≥ 72 h. They passed the spontaneous breathing trial (SBT) safety screen, underwent a 30-min-SBT without indication for extubation and continued to require sedation. Patients were randomized into group M-D (midazolam was switched to dexmedetomidine), group M-P (midazolam was switched to propofol), and group M (sedation with midazolam alone), and sedatives were titrated to achieve the targeted sedation range (RASS − 2 to 0). Results Total 252 patients were enrolled. Patients in group M-D had an earlier recovery, faster extubation, and more percentage of time at the target sedation level than those in group M-P and group M (all P 0.05). Conclusions The sequential use of midazolam and dexmedetomidine was an effective and safe sedation strategy for long-term sedation and could provide clinically relevant benefits for selected critically ill, mechanically ventilated patients. Trial registration NCT02528513 . Registered August 19, 2015.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1364-8535
Relation: https://doaj.org/toc/1364-8535
DOI: 10.1186/s13054-022-03967-5
URL الوصول: https://doaj.org/article/c4b950dc52824f39807621022e075baf
رقم الأكسشن: edsdoj.4b950dc52824f39807621022e075baf
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:13648535
DOI:10.1186/s13054-022-03967-5